|Price:|| $49.95|| |
Release Date: May 16, 2016
Expiration Date: May 15, 2019
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States; an estimated 79 million Americans are currently infected with HPV and each year approximately 14 million people are newly infected. There is a growing body of research demonstrating the increasing incidence of HPV-related cancer in the oropharynx, which includes the tonsillar area and base of the tongue. As is the case with other cancers, early detection and timely treatment of HPV-related oral cancers can reduce the number of deaths from this disease.
Dental professionals are well positioned to play a role in the education, prevention, diagnosis, and treatment of HPV-related oral cancer. Regular dental checkups that include a comprehensive head and neck examination can be beneficial in the early identification of precancerous and cancerous lesions. Dental patients may have questions about their risk of infection, their risk of developing cancer, and the protective value of available HPV vaccines. The established relationship between HPV and oral cancer will require dental providers to expand traditional patient education topics (i.e., tobacco and alcohol) to include information on HPV and develop communication skills appropriate for responding to patient inquiries and concerns as part of a comprehensive approach to preventive oral health care.
This intermediate-level course provides dentists, dental hygienists, and dental assistants with general information about HPV, evidence of the association between oral HPV and oral cancer, and effective ways to further communicate this information to patients. This course provides dental professionals with information that will enable them to effectively meet the challenges they face as the link between HPV and oral health continues to emerge.
AGD Subject Code: 750
Western Schools designates this activity for 5 continuing education credits.
|Price:|| $29.95|| |
Review Date: January 27, 2017
Expiration Date: January 26, 2020
Original Release Date: July 30, 2013
Cancer patients who receive radiotherapy, chemotherapy, and bone marrow or solid organ transplants are at increased risk for orofacial infection and systemic complications. The breakdown of the oral mucosa in patients with cancer may be caused by primary effects of the infectious agent, underlying systemic disease, or the toxic and immunosuppressive effects of therapy.
This basic-level course, appropriate for dentists, hygienists, and assistants, reviews the oral effects of chemotherapy, including alterations in the oral mucosa; the different oral lesions and oral infections usually seen in patients undergoing chemotherapy; and how to best manage patients’ oral health needs before, during, and after chemotherapy treatment. The dental professional’s goals in caring for this segment of the patient population are to maintain the integrity of the oral mucosa, prevent secondary infection, provide pain relief, and maintain dietary intake.
AGD Subject Code: 750
Western Schools designates this activity for 3 continuing education credits.